Drug Trial Radar · NCT03997370
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
350
Planned (sponsor's estimate)
Start
Jan 15, 2020
Primary completion
Mar 14, 2028
Study completion Mar 14, 2028
Sponsor
- Lead sponsor
- NRG OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jun 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial studies how well iohexol works in helping doctors calculate the dose of carboplatin given to patients with cancer. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Understanding how to best calculate the dose of carboplatin given to patients with cancer may help doctors learn how to improve the use of carboplatin in the future.
Conditions
- Malignant Solid Neoplasm
Interventions
Biospecimen CollectionProcedure
Undergo collection of blood samples
CarboplatinDrug
Given IV
IohexolDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accuracy of achieving the targeted carboplatin area under the curve (AUC)Time frame: Up to 4 weeks
- Precision of achieving the targeted carboplatin AUCTime frame: Up to 4 weeks
- Bias of the formula for estimated glomerular filtration rate (eGFR) currently in existence in patients with cancerTime frame: Up to 4 weeks
- Precision of the formula for eGFR currently in existence in patients with cancerTime frame: Up to 4 weeks
- Correlation between carboplatin clearance (CL) and mGFRTime frame: Up to 4 weeks
Locations
189 sites in 2 countries. Site status is shown where the registry gives one.
University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CARTI Cancer Center
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
UC San Diego Health System - Encinitas
Encinitas, California
UC San Diego Moores Cancer Center
La Jolla, California
University of California Davis Comprehensive Cancer Center
Sacramento, California
UC San Diego Medical Center - Hillcrest
San Diego, California
UCHealth University of Colorado Hospital
Aurora, Colorado
Poudre Valley Hospital
Fort Collins, Colorado
Cancer Care and Hematology-Fort Collins
Fort Collins, Colorado
UCHealth Greeley Hospital
Greeley, Colorado
Medical Center of the Rockies
Loveland, Colorado
Hartford Hospital
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Sibley Memorial Hospital
Washington D.C., District of Columbia
Emory University Hospital Midtown
Atlanta, Georgia
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho
Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho
Kootenai Health - Coeur d'Alene
Coeur d'Alene, Idaho
Walter Knox Memorial Hospital
Emmett, Idaho
Idaho Urologic Institute-Meridian
Meridian, Idaho
Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho
Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho
Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho
OSF Saint Anthony's Health Center
Alton, Illinois
Saint Mary's Hospital
Centralia, Illinois
Northwestern University
Chicago, Illinois
University of Chicago Comprehensive Cancer Center
Chicago, Illinois
Carle at The Riverfront
Danville, Illinois
Carle Physician Group-Effingham
Effingham, Illinois
NorthShore University HealthSystem-Evanston Hospital
Evanston, Illinois
NorthShore University HealthSystem-Glenbrook Hospital
Glenview, Illinois
NorthShore University HealthSystem-Highland Park Hospital
Highland Park, Illinois
Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois
Carle Physician Group-Mattoon/Charleston
Mattoon, Illinois
Showing 40 of 189 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.